rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2004-8-9
|
pubmed:abstractText |
Thrombomodulin (TM) is an endothelial cell surface thrombin-binding protein with anticoagulation ability by thrombin-mediated activation of protein C. An increase of plasma soluble TM level is reported to be associated with severity and worse outcome of coronary artery disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0160-9289
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
407-10
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:15298041-Aged,
pubmed-meshheading:15298041-Angioplasty, Balloon, Coronary,
pubmed-meshheading:15298041-Biological Markers,
pubmed-meshheading:15298041-C-Reactive Protein,
pubmed-meshheading:15298041-Coronary Angiography,
pubmed-meshheading:15298041-Coronary Artery Disease,
pubmed-meshheading:15298041-Creatine Kinase,
pubmed-meshheading:15298041-Creatine Kinase, MB Form,
pubmed-meshheading:15298041-Female,
pubmed-meshheading:15298041-Humans,
pubmed-meshheading:15298041-Isoenzymes,
pubmed-meshheading:15298041-Male,
pubmed-meshheading:15298041-Middle Aged,
pubmed-meshheading:15298041-Prospective Studies,
pubmed-meshheading:15298041-Solubility,
pubmed-meshheading:15298041-Statistics as Topic,
pubmed-meshheading:15298041-Taiwan,
pubmed-meshheading:15298041-Thrombomodulin,
pubmed-meshheading:15298041-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
Elevation of the soluble thrombomodulin levels is associated with inflammation after percutaneous coronary interventions.
|
pubmed:affiliation |
Department of Internal Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Evaluation Studies
|